|
Dr. Sacksteder began as a Director and Project Manager at Sequella, and was promoted to Vice President in 2005. She now manages all aspects of diagnostics research and development, from basic science to clinical studies, and is responsible for leading scientific discussions in support of alliance development. In her time at the company, she has been responsible for obtaining significant funding for development of the diagnostic products, as well as for developing and implementing the Phase III clinical trial of the Sequella lead product, the TB Patch Test. She is a scientist who obtained her Ph.D. training in biological chemistry, cellular and molecular biology at the Johns Hopkins University School of Medicine in Baltimore, MD. | 